Sodium (2S,8R)-2-amino-5-hydroxy-11-oxo-8-[(2H27)tetradecanoyloxy](12,12,13,13,14,14,15,15,16,16,17,17,18,18,19,19,20,20,21,21,22,22,23,23,24,24,24-2H27)-4,6,10-trioxa-5-phosphatetracosan-1-oate 5-oxide

Modify Date: 2024-01-14 09:09:56

Sodium (2S,8R)-2-amino-5-hydroxy-11-oxo-8-[(2H27)tetradecanoyloxy](12,12,13,13,14,14,15,15,16,16,17,17,18,18,19,19,20,20,21,21,22,22,23,23,24,24,24-2H27)-4,6,10-trioxa-5-phosphatetracosan-1-oate 5-oxide Structure
Sodium (2S,8R)-2-amino-5-hydroxy-11-oxo-8-[(2H27)tetradecanoyloxy](12,12,13,13,14,14,15,15,16,16,17,17,18,18,19,19,20,20,21,21,22,22,23,23,24,24,24-2H27)-4,6,10-trioxa-5-phosphatetracosan-1-oate 5-oxide structure
Common Name Sodium (2S,8R)-2-amino-5-hydroxy-11-oxo-8-[(2H27)tetradecanoyloxy](12,12,13,13,14,14,15,15,16,16,17,17,18,18,19,19,20,20,21,21,22,22,23,23,24,24,24-2H27)-4,6,10-trioxa-5-phosphatetracosan-1-oate 5-oxide
CAS Number 327178-93-8 Molecular Weight 756.177
Density N/A Boiling Point N/A
Molecular Formula C34H11D54NNaO10P Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Sodium (2S,8R)-2-amino-5-hydroxy-11-oxo-8-[(2H27)tetradecanoyloxy](12,12,13,13,14,14,15,15,16,16,17,17,18,18,19,19,20,20,21,21,22,22,23,23,24,24,24-2H27)-4,6,10-trioxa-5-phosphatetracosan-1-oate 5-oxide


1,2-Dimyristoyl-sn-glycero-3-phospho-L-serine-d54 (sodium) is deuterium labeled 1,2-Dimyristoyl-sn-glycero-3-phospho-L-serine.

 Names

Name Sodium (2S,8R)-2-amino-5-hydroxy-11-oxo-8-[(2H27)tetradecanoyloxy](12,12,13,13,14,14,15,15,16,16,17,17,18,18,19,19,20,20,21,21,22,22,23,23,24,24,24-2H27)-4,6,10-trioxa-5-phosphatetracosan-1-oate 5-oxide
Synonym More Synonyms

  Biological Activity

Description 1,2-Dimyristoyl-sn-glycero-3-phospho-L-serine-d54 (sodium) is deuterium labeled 1,2-Dimyristoyl-sn-glycero-3-phospho-L-serine.
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[2].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.

 Chemical & Physical Properties

Molecular Formula C34H11D54NNaO10P
Molecular Weight 756.177
Exact Mass 755.763306

 Synonyms

Sodium (2S,8R)-2-amino-5-hydroxy-11-oxo-8-[(H)tetradecanoyloxy](12,12,13,13,14,14,15,15,16,16,17,17,18,18,19,19,20,20,21,21,22,22,23,23,24,24,24-H)-4,6,10-trioxa-5-phosphatetracosan-1-oa te 5-oxide
Tetradecanoic-d acid, (1R)-1-[[[[(2S)-2-amino-2-carboxyethoxy]hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, sodium salt (1:1)